Bicycle Therapeutics
BCYC | NASDAQ
$3.63
-$0.02 (-0.55%)
At close: Sep 21, 2026, 4:00 PM ET
$3.63
$0 (0.00%)
After-hours:
Sep 21, 2026, 7:30 PM ET
Market Data
Market Cap $253.29M
Enterprise Value $-244.47M
Beta 1.54
Average Volume 394.11K
Shares Outstanding (Diluted) 69.8M
Shares Change YoY 0.8%
Institutional Ownership 53.76%
Exchange NASDAQ
ISIN US0887861088
Price Performance
Price Change 1M -16.2%
Price Change 3M -9.3%
Price Change 6M -22.4%
Price Change YTD -45.7%
Price Change 1Y -49.1%
Price Change 3Y -81.9%
Price Change 5Y -91.6%
1M CAGR (ann.) -8.1%
1Y CAGR (ann.) -47.3%
5Y CAGR (ann.) -38.0%
All-Time CAGR -15.0%
Valuation
PE Ratio -1.33
Forward PE N/A
PEG Ratio -0.06
Forward PEG 0.30
PS Ratio 4.12
Forward PS 27.10
PB Ratio 0.49
P/FCF Ratio -1.23
P/Adj. FCF Ratio -1.26
P/OCF Ratio -1.23
EV/Sales -3.99
EV/EBIT 1.30
EV/EBITDA 1.33
EV/FCF 1.19
Earnings Yield -75.2%
FCF Yield -81.6%
Adj. FCF Yield -79.3%
Financial Health
Net Cash $510.05M
Total Debt $13.68M
Cash & Short-Term Investments $510.05M
Total Assets $606.58M
Current Ratio 12.08
Quick Ratio 12.08
Debt / Equity Ratio 0.03
Debt / EBITDA -0.07
Debt / FCF -0.07
OCF / Debt -15.04
Interest Coverage -1,089.93
Altman Z-Score -0.64
Piotroski F-Score 3
Margins & Profitability
Gross Profit Margin 100.0%
Operating Profit Margin -343.7%
EBITDA Margin -299.3%
Net Profit Margin -311.1%
FCF Margin -335.9%
Adj. FCF Margin -326.6%
SBC / Revenue -9.3%
SBC Impact (per share) -2.8%
Returns
Return on Assets -31.4%
Return on Equity -33.2%
Return on Invested Capital -37.6%
Return on Capital Employed -37.6%
Return on Tangible Assets -31.4%
Historical Growth (CAGR)
Revenue CAGR 3Y 39.6%
Revenue CAGR 5Y 40.2%
Revenue CAGR 10Y N/A
EPS CAGR 3Y 16.1%
EPS CAGR 5Y 5.1%
EPS CAGR 10Y N/A
FCF CAGR 3Y -10.5%
FCF CAGR 5Y -33.5%
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Buy
Analyst Count 21
EPS Growth Next 3Y 5.3%
Revenue Growth Next 3Y -22.3%
Earnings Date N/A
EPS Estimate (next Q) N/A
EPS Growth Est (next Q) N/A
Revenue Est (next Q) N/A
Revenue Growth Est (next Q) N/A
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $12
Price Target Upside 230.6%
Cash Flow
Operating Cash Flow $-205.72M
Free Cash Flow $-205.59M
Adj. Free Cash Flow $-199.89M
FCF Per Share -$2.95
OCF Per Share -$2.95
OCF/S Ratio -336.1%
Income Statement
Revenue $61.21M
Gross Profit $61.21M
Operating Income $-210.36M
EBITDA $-183.2M
Net Income $-190.41M
EPS (Diluted) -$2.73
Revenue / Employee $212.52K
Profit / Employee $-661.15K
Employees 288
Add to Watchlist
Select watchlists to add or remove BCYC